课题基金 / 基金详情

Mechanism of prostasin-induced aldosterone production

Mechanism of prostasin-induced aldosterone production
前列腺素诱导醛固酮产生的机制
批准号:
20390238
负责人:
TOMITA Kimio
金额:
$11.81万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

TOMITA Kimio的其他基金

相似基金

相关文献

中文摘要
翻译
血压(BP)和细胞外液量的控制主要取决于肾脏对钠重吸收和排泄的调节。上皮钠通道(ENaC)通过调节肾脏中的钠重吸收而在血压调节中起重要作用。我们以前发现,前列腺素增加钠运输通过ENaC在共表达系统中使用非洲爪蟾卵母细胞,和醛固酮增加了丰富的前列腺素在人类和大鼠尿液和小鼠皮质集合管细胞系的培养基中,我们检查,如果前列腺素增加醛固酮合成在人类肾上腺皮质细胞系(H295R细胞)。使用CYP11B2启动子的荧光素酶测定用于观察前列腺素是否增加CYP11B2的转录活性。此外,在盐敏感性高血压的模型动物Dahl高血压大鼠中研究ENaC活性。
英文摘要
The control of blood pressure (BP) and extracellular fluid volume primarily depends on renal regulation of sodium reabsorption and excretion. The epithelial sodium channel (ENaC) plays an important role in the regulation of blood pressure by modulating Na reabsorption in the kidney. We previously revealed that prostasin increased Na transport through ENaC in the co-expression system using Xenopus oocytes, and that aldosterone increased the abundance of prostasin in human and rat urine and in the cultured medium of a mouse cortical collecting duct cell line.We examine if prostasin increases the aldosterone synthesis in a human adrenocortical cell line (H295R cells). Luciferase assay using CYP11B2 promoter is used to see if the prostasin increases the transcriptional activity of CYP11B2. In addition, ENaC activity is investigated in Dahl hypertensive rats which are the model animal of salt-sensitive hypertension.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1097/hjh.0b013e32832c7d23
发表时间: 2009-08-01
期刊: JOURNAL OF HYPERTENSION
影响因子: 4.9
作者: [Kakizoe, Yutaka, Kitamura, Kenichiro, Tomita, Kimio]
通讯作者: Tomita, Kimio
DOI: 10.1074/jbc.m110.121301
发表时间: 2010-11-05
期刊: JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子: 4.8
作者: [Jutabha, Promsuk, Anzai, Naohiko, Sakurai, Hiroyuki]
通讯作者: Sakurai, Hiroyuki
DOI: 10.1038/hr.2009.6
发表时间: 2009-04-01
期刊: HYPERTENSION RESEARCH
影响因子: 5.4
作者: [Koda, Aya, Wakida, Naoki, Kitamura, Kenichiro]
通讯作者: Kitamura, Kenichiro
DOI: 10.1038/hr.2009.52
发表时间: 2009-08
期刊: Hypertension Research
影响因子: 5.4
作者: [S. Wakamatsu;H. Nonoguchi;M. Ikebe;K. Machida;Y. Izumi;Hasiyet Memetimin;Y. Nakayama;T. Nakanishi;Y. Kohda;K. Tomita]
通讯作者: S. Wakamatsu;H. Nonoguchi;M. Ikebe;K. Machida;Y. Izumi;Hasiyet Memetimin;Y. Nakayama;T. Nakanishi;Y. Kohda;K. Tomita
共 16 条
    Development of drug by use of protease cascade of prostasin
    • 批准号:
      18390252
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.51万
    • 财政年份:
      2006
    • 负责人:
      TOMITA Kimio
    • 依托单位:
    Antibody treatment against hypertension
    • 批准号:
      16390246
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.77万
    • 财政年份:
      2004
    • 负责人:
      TOMITA Kimio
    • 依托单位:
    Analysis of the function of prostasin in the transgenic mice.
    • 批准号:
      14370321
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.83万
    • 财政年份:
      2002
    • 负责人:
      TOMITA Kimio
    • 依托单位:
    Role of renal arginase in acute renal failure
    • 批准号:
      11470219
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $9.34万
    • 财政年份:
      1999
    • 负责人:
      TOMITA Kimio
    • 依托单位:
    海外基金